Medical Equipment

Life Science Tools Market Expansion Outlook: $335.13 Billion by 2029 Forecast

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Life Science Tools Market From 2025 To 2034?

The life science tools market has shown rapid expansion in recent years. It is anticipated to increase from $176.74 billion in 2024 to $201.37 billion in 2025, achieving a compound annual growth rate (CAGR) of 13.9%. This historical growth can be linked to the rising incidence of chronic and infectious diseases, increasing production volumes in the pharmaceutical and biotechnology sectors, heightened demand for clinical diagnostic testing, the expansion of environmental and food safety testing, and greater integration of automation in laboratory operations.

The life science tools market is projected for significant expansion over the coming years, reaching $335.13 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 13.6%. This growth during the forecast period is propelled by several factors, including the increasing need for tools to develop personalized treatments, the expansion of manufacturing capabilities for cell and gene therapies, a heightened demand for high-purity reagents in industrial settings, the rising adoption of decentralized diagnostic testing, and the increased production of biologics and biosimilars. Key trends anticipated in this period encompass the integration of cloud-based platforms for laboratory data management, a movement towards multi-omics approaches in research, the utilization of cryo-electron microscopy for detailed imaging, the customization of lab instruments for specialized research fields, and the expansion of lab-on-a-chip and microfluidic technologies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27329&type=smp

What Are The Drivers Pushing New Developments In The Life Science Tools Market?

The increasing need for biopharmaceuticals is projected to boost the expansion of the life science tools market in the future. Biopharmaceuticals are medical drugs created through biotechnology, utilizing biological origins like living cells or organisms to develop treatments such as proteins, antibodies, or vaccines. This growing demand for biopharmaceuticals stems mainly from their effectiveness in treating intricate and long-term illnesses that conventional small-molecule medications struggle to tackle sufficiently. Life science tools are crucial for the creation and production of biopharmaceuticals, offering vital technologies for research, analysis, and quality control during the entire drug manufacturing process, thereby guaranteeing precision, efficiency, and adherence to regulatory requirements. For example, data from Cardinal Health Inc., a US-based healthcare company, indicated that in January 2023, the US had 33 biosimilar products approved by the FDA as of January 2022, with 21 commercially launched. By 2023, the total number of FDA-approved biosimilars had increased to 40, with 25 accessible in the market. Consequently, the increased demand for biopharmaceuticals is a key factor propelling the expansion of the life science tools market.

What Are The Major Segments Identified In The Life Science Tools Market?

The life science tools market covered in this report is segmented

1) By Type: Instruments, Consumables, Services

2) By Technology: Polymerase Chain Reaction(PCR) And Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, Separation Technologies, Flow Cytometry, Nucleic Acid Microarray, Mass Spectrometry, Other Technologies

3) By Application: Drug Discovery And Development, Clinical Diagnostics, Genomic And Proteomic Research, Cell Biology Research, Other Applications

4) By End-User: Academic And Research Institutions, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostic Laboratories, Contract Research Organizations (CROs), Government And Regulatory Agencies

Subsegments:

1) By Instruments: Microscopes, Sequencers, Analyzers, Spectrometers, Centrifuges, Chromatography Systems, Laboratory Automation Equipment

2) By Consumables: Reagents, Kits, Culture Media, Pipettes And Tips, Plasticware, Laboratory Chemicals, Assay Kits

3) By Services: Calibration Services, Maintenance And Repair, Laboratory Testing Services, Consulting Services, Training And Support, Research And Development Services

What Key Innovation Trends Are Fueling Advancements In The Life Science Tools Market?

Major companies operating in the life science tools market are channeling efforts into developing innovative solutions, such as automated sequencing platforms, to enhance efficiency, accuracy, and accessibility in genetic analysis, thereby accelerating research and clinical diagnostics. Automated sequencing platforms represent advanced systems that perform DNA or RNA sequencing with minimal manual intervention, leveraging robotics and software to increase throughput, reduce errors, and enable faster, more reliable genetic research and diagnostics. For instance, in October 2024, Illumina Inc., a US-based biotechnology company, launched the MiSeq i100 series, its simplest and fastest benchtop sequencers designed to make next-generation sequencing more accessible to a wider range of laboratories. The new MiSeq i100 and MiSeq i100 Plus Systems offer room-temperature kit storage and shipping, eliminating delays caused by reagent thawing and enabling same-day sample-to-analysis workflows. These platforms provide rapid sequencing with run times as short as four hours, along with cost-effective consumables and user-friendly, push-button workflows that support various applications in microbiology, infectious disease, and oncology. This innovation exemplifies the market’s shift toward efficient, scalable, and easy-to-use sequencing tools that empower researchers and clinicians alike.

Which Global Market Leaders Are Shaping The Future Of The Life Science Tools Sector?

Major companies operating in the life science tools market are F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Lonza Group Ltd., Illumina Inc., Sartorius AG, Shimadzu Corporation, Revvity Inc., Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Eppendorf AG, Tecan Group Ltd., Bio-Techne Corporation, Takara Bio Inc., GenScript Biotech Corporation, 10x Genomics Inc., and Hamilton Company.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/life-science-tools-global-market-report

Which Regional Markets Are Contributing Most To The Life Science Tools Industry Expansion?

North America was the largest region in the life science tools market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the life science tools market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Life Science Tools Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27329&type=smp

Browse Through More Reports Similar to the Global Life Science Tools Market 2025, By The Business Research Company

Alternative Finance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/alternative-finance-global-market-report

Finance Cloud Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/finance-cloud-global-market-report

Online Trading Platform Market 2025

https://www.thebusinessresearchcompany.com/report/online-trading-platform-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795